- Research article
- Open Access
Binding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals
© Zhang et al; licensee BioMed Central Ltd. 2009
- Received: 29 July 2008
- Accepted: 25 February 2009
- Published: 25 February 2009
Health risk from exposure of perfluorochemicals (PFCs) to wildlife and human has been a subject of great interest for understanding their molecular mechanism of toxicity. Although much work has been done, the toxigenicity of PFCs remains largely unknown. In this work, the non-covalent interactions between perfluorooctane sulfonate (PFOS) and serum albumin (SA) and DNA were investigated under normal physiological conditions, aiming to elucidate the toxigenicity of PFCs.
In equilibrium dialysis assay, the bindings of PFOS to SA correspond to the Langmuir isothermal model with two-step sequence model. The saturation binding number of PFOS was 45 per molecule of SA and 1 per three base-pairs of DNA, respectively. ITC results showed that all the interactions were spontaneous driven by entropy change. Static quenching of the fluorescence of SA was observed when interacting with PFOS, indicating PFOS bound Trp residue of SA. CD spectra of SA and DNA changed obviously in the presence of PFOS. At normal physiological conditions, 1.2 mmol/l PFOS reduces the binding ratio of Vitamin B2 to SA by more than 30%.
The ion bond, van der Waals force and hydrophobic interaction contributed to PFOS binding to peptide chain of SA and to the groove bases of DNA duplex. The non-covalent interactions of PFOS with SA and DNA alter their secondary conformations, with the physiological function of SA to transport Vitamin B2 being inhibited consequently. This work provides a useful experimental method for further studying the toxigenicity of PFCs.
- Isothermal Titration Calorimetry
- Equilibrium Dialysis
- Sulfonic Acid Group
- Dynamic Quenching
- Dialysis Solution
Biomolecules such as proteins and DNA have been a subject of great interest for the last hundreds of years because of their key functional roles in the cellular processes. Serum albumin is the major protein component of blood plasma. It is responsible for the maintenance of oncotic pressure of blood plasma  as well as that of blood pH . It is the well-known model protein and is called a multifunctional plasma carrier protein for its ability to bind a wide variety of ligands. These include inorganic cations, organic anions, amino acids, and, perhaps most important, physiologically available insoluble endogenous compounds, e.g., fatty acids [3–7], bilirubin , and bile acids. The locations of the fatty acid binding sites throughout the protein have been mapped by structural study [6, 7]. In fact, not only endogenous ligands but also exogenous compounds bind to HSA, for example, commonly used drugs with acidic or electronegative features, e.g., warfarin , camptothecins  and inorganic polymers such as polyoxometalates . Recently, the binding mechanism of organic contaminants or toxins to HSA has been investigated, e.g. arazine , ochratoxin , methyl parathion , and arsenic . The interactions of organic contaminants with serum albumin often cause conformational change in the protein or even the subsequent change of its physiological function. Concerning to DNA, whose conformation and sequence preference is critical to replication, transcription and DNA chromatin compaction , it is reported that DNA is subjected to the effect of organic chemicals, too, whether it is endogenous ligands or exogenous compounds. As the target of many drugs [16, 17] and also most likely of a large number of environmental pollutants [18, 19], DNA has been extensively studied about the binding mechanism such as minor groove binding, major groove binding, and (bis)intercalation. For example, Distamycin A, a well-known polyamide antibiotic, can bind in the minor groove of duplex DNA primarily at AT-rich sequences as a monomer or as a side-by-side antiparallel dimer. Its binding affinity derives from specific hydrogen bonding contacts between the amide protons and the O2 or N3 of pyrimidines and purines, respectively, electrostatic interactions with the backbone, and van der Waals contacts with the walls of the minor groove . In fact, the involvement of any substances is likely to affect the activity of the biomolecule, either enhancing it  with potential medical significance or inhibiting it  if it is associated with an organic contaminant or toxin. After all, there is still a lot unknown about the binding mechanism of biomolecules.
For over half a century, perfluorochemicals (PFCs) have been extensively used in a variety of consumer and industrial applications due to their physical and chemical properties: chemical stability, thermal inertness, low surface energy and an amphiphilic nature [23, 24]. Given their physical and chemical properties, PFCs have been found not only persistent in the environment, bioaccumulative through food chain but also ubiquitously distributed all over the world [25–35] including the Arctic, Antarctic and Pacific region. Several studies have been conducted on the presence and levels of PFCs in marine mammals, fish, birds, and humans [25–35]. PFOS were found in high concentrations in liver tissue in top predators, polar bears, and even in the cord serum of newborns in many countries [33, 36–38]. Recently, PFCs have been identified as new persistent organic pollutants . Laboratory studies have reported the developmental and reproductive toxicity [40–45], neurotoxicity [46–49], immunotoxicity [50, 51] and carcinogenicity [52, 53] of PFOS in rodents both in vivo and in vitro. At cellular, molecular and gene levels, PFOS was found to cause peroxisomal proliferation [54, 55], change of membrane surface potential , mitochondrial dysfunction , disturbance of fatty acid metabolism , hepatocellular hypertrophy  and even change of gene expression . In 2000, 3 M, the major manufacturer of these compounds, announced the discontinuation of its perfluorooctane-based compounds due to concerns regarding persistence, worldwide dissemination, toxicity, and bioaccumulation.
Elucidation of the mechanism of biomolecular interactions such as protein-protein  and DNA-ligand binding [16, 17], enzyme catalysis, and inhibition is crucial to understanding of cellular processes including signal transduction, gene regulation, and enzyme reactions . Conventional molecular spectrometric methods such as fluorescent probe, UV, and circular dichroism (CD) have been widely used for the investigation of protein-ligand interaction. Recently, binding mechanisms have been studied using equilibrium dialysis, x-ray crystallography, NMR, isothermal titration calorimetry (ITC), and surface plasmon resonance biosensors [63, 6, 64, 17, 65], which are powerful analytical tools in enzymology, rational drug design, and toxicology. In this study, equilibrium dialysis, fluorophotometry, ITC and CD were used to characterize the non-specific interactions between PFOS and SA/DNA in the normal physiological condition, pH 7.4 and 0.15 M electrolyte and 37°C. The object is to analyze the interaction forces, sites and type and then further understand the toxigenicity of PFCs.
Characterization of the interactions of PFOS with SA and DNA
HPLC-MS was used to validate the simple colorimetric detection method for the determination of PFOS during dialysis process. The two methods have achieved the consistent results in the measurement of three PFOS dialysis solutions (see Additional File 1). Therefore, the colorimetric method is feasible for the determination of PFOS in the present work. The interaction of PFOS (L) with SA and DNA (M) can be summarized below:
where K is the adsorption constant. The plots of γ-1 versus cL-1 are shown in Fig. 1B. The good linear relationships of the plots indicate that the bindings of PFOS to peptide chains and DNA duplex obey the Langmuir isothermal model. The interactions of PFOS with SA and DNA are the chemical adsorption in monolayer. From the intercepts of the regression lines in Fig. 1B, N of PFOS molecules bound per molecule of SA and per bp of DNA was calculated to be 45 and 0.36, respectively.
The electrostatic attraction plays an important role in the binding of sulfonic ligands to proteins. Several studies in our laboratory have revealed that electrostatic attraction between the sulfonic groups of azo compounds and the positively charged amino acid residues (AARs) of SA is the main contributor that fixes the position of these compounds in protein in acidic media and induces the subsequent combined actions of multiple non-covalent bonds, e.g., hydrogen bonds, hydrophobic interactions and van der Waals force [67, 68]. Given the dissociation constants (KR) of the side groups (R) of basic and acidic AARs of SA (10.53 for Lys, 6.00 for His, 12.48 for Arg, 3.65 for Asp, and 4.25 for Glu), only the side groups of Lys and Arg residues are protonated and positively charged in neutral solutions in our study, so selectrostatic attraction between the sulfonic acid group of PFOS and positively charged AARs of SA will be much weaker than that in acidic media. But concerning the high polarity of PFOS, the electrostatic attraction between the sulfonic acid group of PFOS and the positively charged -NH3+ groups of Lys and Arg of SA can still play an important role in the PFOS-SA binding [69, 70]. Moreover, the hydrophobic interaction will also occur between the long alkyl group of PFOS and the nonpolar side groups of AARs of SA such as Lys, Arg, His and so on. Similarly, PFOS may bind to DNA via hydrophobic interaction resulting from the long alkyl group and the homolateral bases in the groove of DNA.
Effects of pH, electrolytes and temperature
Sodium chloride was added in the PFOS-SA/DNA solutions to investigate the effect of electrolyte on the non-covalent interaction. Human blood normally contains approximately 0.15 mol/l electrolyte. Although γ of PFOS-SA binding (Fig. 2B) increases when the electrolyte is less than 0.15 mol/l, γ is only slightly different in 0.15 mmol/l electrolyte from that in 0.25 mol/l electrolyte. This implies that ions in human blood would not affect PFOS binding. From the curves in Fig. 2B, a peak of γ of the PFOS-DNA binding appears at 0.25 mol/l electrolyte, indicating that ions in body fluids will affect the PFOS-DNA binding more or less.
High temperature has two opposing effects on non-covalent interaction. On one hand, the peptide chain and DNA duplex will expand with heating and the three-dimensional conformation will be favorable for the insertion of organic molecules. On the other hand, such expansion will increase the distance between peptide chains and DNA duplex, leading to the redistribution of the effective binding sites on the peptide chain and DNA duplex and the subsequent desorption of small organic substances . The balance between these mechanisms decides the effect of temperature on the non-covalent interactions. As is shown in Fig. 2C, γ values for the PFOS-SA/DNA interactions decrease with increasing of temperature. Obviously the distance between the peptide chains or DNA duplex increases as a result of temperature increase and lead to the desorption of PFOS, which result from the subsequent decrease of binding sites for PFOS. Therefore, γ values of the PFOS-SA/DNA interactions decrease.
The intrinsic fluorescence analysis of Trp residues of SA
SA contains a hydrophobic cavity and all hydrophobic AARs were present in the cavity , including Trp residue, which is favorable for hydrophobic group to enter. PFOS enters the cavity and interacts with the hydrophobic AARs via hydrophobic interaction between the alkyl group of PFOS and the aromatic group of AARs, causing the quenching of SA fluorescence. In addition, concerning the high polarity of the sulfonic acid group of PFOS, the electrostatic attraction could occur between the sulfonic acid group of PFOS and -NH3+ of Lys and Arg residues of SA.
Variation of the secondary conformation of SA and DNA
The combinations of covalent and non-covalent interactions among a protein or DNA result in the specific conformation and the corresponding function of biomolecules. When organic compounds such as a pollutants, drugs or toxicants interact with protein or DNA, the internal non-covalent bonds of the peptide chain or DNA duplex are often disrupted, possibly changing the original conformation or even their special function. CD spectrometry is often used to evaluate the secondary structure of DNA  or a protein , such as the fractions of β-pleated sheet, α-helix and β-turn.
The CD spectra of DNA in the 230–300 nm scope show a signal characteristic of a B-form helix with a negative band at 245 nm and a positive band at 275 nm. The enhancement of CD spectra at both 245 and 275 nm in the presence of PFOS and the shape change of the positive and negative band (Fig 4C) indicated that PFOS binds in the groove of DNA. On account of the hydrophobic alkyl group of PFOS, PFOS may bind in the groove of DNA paralleling with the phosphate backbone via van der Waals force and hydrophobic interaction. Thus, the electron cloud of bps becomes expanding owing to the reversed pulling of PFOS so as to the enhancement of CD of DNA at 275 nm.
Thermodynamic characterization of the interactions of PFOS with SA and DNA
Relating thermodynamic parameters to structural and biochemical data allows a better understanding of the mechanism of the biomolecule-ligand reaction. The ITC measurements provide information on thermodynamic quantities such as enthalpy and heat capacity changes during the molecular interaction based on the heat produced by reactions In recent years, ITC measurements have been widely applied to study e.g. protein-ligand interaction , DNA-ligand interaction .
The ITC experiments were conducted by injecting PFOS solutions into the ITC cell containing SA or DNA in pH 7.40 media at 37°C. In each experiment, an exothermic heat pulse was detected following each injection. Its magnitude progressively decreased until a plateau is reached indicating saturation of binding. The heat involved at each injection was corrected for the heat of dilution, which was determined separately by injecting the PFOS solutions into the B-R buffer and then divided by the number of moles injected. Values for the equilibrium binding constant (Kb), enthalpy change (ΔH), and entropy change (ΔS) of the reaction were obtained and calculated by the Gibbs free energy (ΔG) equation:
ΔG = -RT ln K D = ΔH - T ΔS
From Fig. 5A, the binding of PFOS to SA corresponds to two-step sequence model: on the surface and inside the cavity. First, the heat released from PFOS-SA interactions was negative when cL0/cM0 < 10, indicating the occurrence of exothermic reaction and the formation of polar bonds. Because the polar bonds are more likely to be formed outside of the hydrophobic cavity of SA, it is suggested that PFOS binds to the surface of SA via electrostatic attraction between the sulfonic acid group of PFOS and -NH3+ of Lys and Arg residues of SA (Fig. 6A). After the binding sites of SA surface had been occupied, PFOS molecules entered the cavity of SA easily (Fig. 6A). When cL0/cM0 > 10, the heat released from the PFOS-SA interaction was positive, indicating the occurrence of endothermic reaction and hydrophobic interaction. Because the hydrophobic interaction is more likely to occur inside of the hydrophobic cavity of SA, it is suggested that PFOS enters hydrophobic cavity of SA and binds to the nonpolar AARs there. For example, PFOS interacts with the aromatic side group of Trp residue of SA. Owing to the small cavity where inside binding occurred and the consequent effect on SA conformation, SA folds and its conformation changes.
As is shown in Fig. 5B, ΔH is very small. Most of the heat released from the PFOS-DNA interaction was positive, indicating the occurrence of endothermic reaction and hydrophobic interaction. PFOS probably interacts hydrophobically with the homolateral bases of DNA via the alkyl group, paralleling with the phosphate backbones of DNA (Fig. 6B). The conformation of DNA changed owing to the hydrophobic interaction that pulls the contiguous bps closer. This is confirmed from high ΔS values (Fig. 5B-2).
Effects of PFOS on the physiological function of SA to transport Vitamin B2
The relationship between structural transformation of protein and its functioning is of great significance in organisms. During interaction process, a small organic compound may bind to the peptide chain, regulating its three-dimensional structure and even changing its corresponding function [80, 81]. Although non-covalent binding is often weak and non-specific, a combination of many non-covalent bonds may alter the conformation and function of the protein . Serum albumin is the most abundant protein of blood plasma. It is responsible for the maintenance of both the oncotic pressure and pH of blood. Moreover, it is the major plasma carrier protein in blood which can bind a large number of ligands, e.g., amino acids, vitamins, fatty acids, drugs and so on.
By characterizing the interaction of PFOS with SA and DNA using various methods, some important results were obtained concerning e.g., binding number, binding energy, and type of binding. The interactions of PFOS with SA and DNA obeyed the Langmuir isothermal model and the saturation mole numbers of PFOS was calculated to be 45 per molecule of SA and 0.36 per bp of DNA. These numbers indicate that PFOS has a high binding capacity especially for SA in vitro. As to the toxicity of PFOS in vivo at concentrations currently observed in the environment, further research needs to be conducted. Both the interactions are driven by entropy increase and spontaneous. The electrostatic attraction and hydrophobic interaction are suggested to occur in PFOS binding to the peptide chain and the grooves of DNA. The combined action of non-covalent bonds results in change of the secondary structure of both SA and DNA, with the binding ratio of VB2 to SA being reduced by more than 30%, indicating the transport function of SA was inhibited consequently. This work provides a useful experimental method for studying the interaction of PFCs with biomacromolecules so as to understand the toxigenicity of PFCs.
Instruments and Materials
A Model F-4500 fluorospectrophotometer (Hitachi High-Technologies Cooperation, Tokyo, Japan) was used for the concentration measurement of vitamin B2 and fluorescence measurement of protein solutions in the presence of PFOS. A Model Lambda-25 spectrometer (Perkin-Elmer, Shelton, CT 06484, USA) was used to determine the concentration of PFOS during the process of equilibrium dialysis. The spectrometer was computer-controlled using UV WinLab software (Version 2.85.04). The Isothermal Titration Calorimetery (ITC) experiments were carried out on a Model VP-ITC system (MicroCal Inc., USA) with VPViewer 2000 (Version 1.04.0018). A Model J-715 CD spectropolarimeter (Jasco Instruments, Tokyo, Japan) with secondary structure estimation-standard analysis measurement software (715/No. B014460524, Jasco) was used to determine the conformation of protein and DNA. Model RC 30-5K semi-permeable membranes (Molecular Weight Cut Off 5 KDa, Shanghai Green Bird STD) were used for equilibrium dialysis. A Model DK-8D electrothermic multiporous constant temperature water-bath (Shanghai Yiheng Technol., Shanghai, China) was used in the temperature experiment. Solution pHs were measured with a Model pHS-25 acidity meter (Shanghai Precise Sci. Instrum., Shanghai, China). An Accela U-HPLC-system connected to a TSQ Quantum Access mass spectrometer (Thermo Fisher Scientific, America) was used to validate the CPC-ECR colorimetric method used for PFOS determination in this study.
Both 0.100 mmol/l SA (Sigma, A7906) and 3.7 mmol/l bps of DNA (Shanghai Chemical Reagents Company, Shanghai, China) were prepared in deionized water as a stock solution and stored at 4°C. The precise concentration of protein and DNA were determined by the UV method. PFOS stock solution (10 mmol/l) was prepared by diluting 1 ml of PFOS water solution (40% in water, Fluka, USA) in 100 ml of deionized water and stored at 4°C. Vitamin B2 stock solution (0.1276 mmol/l) was prepared by dissolving 12 mg of Vitamin B2 (VB2) (purity 99%, Shanghai Chemical Reagents Company, Shanghai, China) in 250 ml of deionized water and stored at 4°C. The 1.25 mol/l NaCl and Britton-Robinson (B-R) buffer (pH 7.40) containing 0.040 mol/l phosphoric acid, acetic acid and boric acid was used for the experiments.
Determination of PFOS with CPC and ECR
PFOS reacts with cetylpyridinium chloride (CPC) by ion-pair binding to form the PFOS-CPC complex . The anionic ligand, eriochrome cyanine R (ECR) was used to replace CPC from the PFOS-CPC complex to form a CPC-ECR complex. The color change was used for determination of PFOS only in this work. The replacement procedures are followed. 2.0 ml pH 3.80 acetate buffer, 0.30 ml 1.00 mM CPC and 0.50 ml 1.00 mM ECR were mixed in 5-ml calibrated flasks. After mixing for 15 min, various amounts of PFOS were added and the solutions diluted to 5 ml. After 10 min, the absorbance of each solution was measured at 626 nm against a reagent blank without PFOS.
Equilibrium of PFOS dialysis and working curve of PFOS determination
To validate the above detection method, a high performance liquid chromatography (HPLC) system coupled to a triple quadrupole mass spectrometer (MS) was used with the method being modified  (Additional File 2). After equilibrium dialysis of 100.0, 150.0, 200.1 mg/l PFOS in SA presence at 37°C for 10 hours, 1.00 ml of the dialysis solution was collected and determined by the above detection method. Meanwhile, another 1.00 ml of the dialysis solution was also collected and determined by HPLC-MS after being diluted for 1000 times. Then a total of 10 μl was injected onto a Hypersil Gold C18 column (150 × 2.1 mm, 5 μm, Thermo) with a 5 mM ammonium acetate (pH 3.5)/methanol mobile phase starting at 10% methanol. At a flow rate of 250 μL/min, the gradient increased to 95% methanol at 13 min before reverting to original conditions at 16 min. Column temperature was maintained at 25°C. For quantitative determination, the HPLC system was interfaced to a TSQ Quantum Access (Thermo) mass spectrometer employing electron spray ionization in the negative ion mode and highly selective reaction monitoring. The fragment ions for PFOS m/z 499 (C8F17SO3-) were monitored for quantification.
Equilibrium dialysis of PFOS in SA and DNA presences
In order to determine the interactions of PFOS with SA or DNA, B-R buffer, 0.15 mol/l NaCl, a known volume of SA or DNA solution (cM0), deionized water and a known volume of PFOS solution (cL0) were added in dialysis bags (1). The temperature (2) of the water bath (4) was kept constant at 37°C. Using the same method, 1 ml of the dialysis solution (3) was collected in 5-ml calibrated flasks from every sampling tube (6). According to the detection method above, the absorbance of the dialysis solution was measured at 626 nm and cL of PFOS was calculated by the working curve. γ of PFOS to SA or DNA was calculated and data were plotted.
Fluorescence measurement of PFOS-SA solutions
The B-R buffer (2.00 ml) and 0.050 ml of 0.100 mmol/l SA were mixed with 0, 2.5, 5, 7.5, 10, 12.5, 15, 17.5 μmol/l of PFOS in 10-ml calibrated flasks. The solutions were diluted to 10 ml with deionized water and their fluorescence intensities were measured at the excitation wavelength (280 nm) and the emission wavelengths (300–450 nm).
CD measurement of SA and DNA conformation in the presence of PFOS
The B-R Buffer (1 ml), 0.04 ml SA (0.100 mmol/l) were mixed with 0, 16, 20, 24, 40 μmol/l PFOS in flasks. The solutions were diluted to 10.0 ml with deionized water. Each sample was allowed to equilibrate for 15 min before measurement. CD spectra were taken on a spectropolarimeter with a 0.1 cm light path cell at 25°C. The mean residue ellipticity (θ) of SA was measured between 190 and 240 nm. From the θ curves, the relative contents of secondary structure forms of SA, α-helix, β-pleated sheet, β-turn and random coil, were calculated in all solutions. The 100 μmol/l DNA containing 0, 20, 30 and 40 μmol/l PFOS were measured between 190 and 240 nm using the same method.
ITC characterization of interactions of PFOS with SA and DNA
ITC experiments were carried out as follows: the PFOS solution (2.50 mmol/l in pH 7.40 B-R buffer) was injected about 27 times in 10-μl increments at 270-S intervals into the isothermal cell containing SA (0.010 mmol/l in pH 7.40 B-R buffer) or DNA (0.500 mmol/l in pH 7.40 B-R buffer). The cell temperature was kept at 37°C. Heats of dilution of PFOS, obtained separately by injecting PFOS into the buffer, were used to correct the raw data. The corrected heats were divided by the number of moles injected and analyzed using the Origin software (version 7.0) supplied by the manufacturer. The titration curve was fitted by a nonlinear least-squares method and ΔH and ΔS were determined.
Effect of PFOS on the physiological function of SA to transport Vitamin B2
The fluorescence intensity of Vitamin B2 (VB2) solution was measured at the excitation wavelength (440 nm) and the emission wavelength (525 nm) against deionized water using fluorospectrophotometer. The determination of the VB2-SA interaction was investigated according to the same equilibrium dialysis method as described above.
For the equilibrium dialysis assay of PFOS-VB2-SA, 12.5 ml solution containing 2.5 ml of B-R buffer, 0.15 mmol/l NaCl, 0.02 mmol/l SA (cM0), 0.041 mmol/l VB2, a known volume of PFOS solution (cL0) and deionized water were pipeted into the dialysis bag (Fig. 8). After 10 hours at 37°C, 2.5 ml of the dialysis solution was collected from the sampling tube and the concentration of VB2 was determined. The binding ratio of VB2 to SA was calculated to investigate the effect of PFOS on the transport function of SA.
We thank the State Key Laboratory Foundation of Science and Technology Ministry of China (STMC) (Grant No. PCRRK08003), the International Cooperation Project of the STMC (2007DFR90050), and the National Major Project of STMC (2008ZX07421-002) for financially supporting this work.
- Shakai N, Garlick RL, Bunn HF: Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J Biol Chem. 1984, 259: 3812-3817.Google Scholar
- Carter DC, Ho JX: Structure of serum albumin. Adv Protein Chem. 1994, 45: 153-203.View ArticlePubMedGoogle Scholar
- Choi JK, Ho J, Curry S, Qin DH, Bittman R, Hamilton JA: Interactions of very long-chain saturated fatty acids with serum albumin. J Lipid Res. 2002, 43: 1000-1010.View ArticlePubMedGoogle Scholar
- Bojesen IN, Bojesen E: Binding of arachidonate and oleate to bovine serum albumin. J Lipid Res. 1994, 35: 770-778.PubMedGoogle Scholar
- Hamilton JA, Era S, Bhamidipati SP, Reed RG: Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc Natl Acad Sci USA. 1991, 88: 2051-2054.PubMed CentralView ArticlePubMedGoogle Scholar
- Bhattacharya AA, Curry S, Franks NP: Binding of the general anesthetics propofol and halothane to human serum albumin: high-resolution crystal structures. J Biol Chem. 2000, 275: 38731-38738.View ArticlePubMedGoogle Scholar
- Zunszain PA, Ghuman J, Komatsu T, Tsuchida E, Curry S: Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct Biol. 2003, 3: 6-PubMed CentralView ArticlePubMedGoogle Scholar
- Petitpas I, Bhattacharya AA, Twine S, East M, Curry S: Crystal structure analysis of warfarin binding to human serum albumin. J Biol Chem. 2001, 276: 22804-22809.View ArticlePubMedGoogle Scholar
- Burk TG, Mi Z: The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. J Med Chem. 1994, 37: 40-46.View ArticleGoogle Scholar
- Rhule JT, Hill CL, Judd DA, Schinazi RF: Polyoxometalates in medicine. Chem Rev. 1998, 98: 327-358.View ArticlePubMedGoogle Scholar
- Purcell M, Neault JF, Malonga H, Arakawa H, Carpentier R, Tajmir-Riahi HA: Interaction of atrazine and 2, 4-D with human serum albumin studied by gel and capillary electrophoresis, and FTIR spectroscopy. Biochim Biophys Acta. 2001, 1548: 129-138.View ArticlePubMedGoogle Scholar
- Berger V, Gabriel AF, Sergent T, Trouet A, Larondelle Y, Schneider YJ: Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2). Toxicol Lett. 2003, 140: 465-476.View ArticlePubMedGoogle Scholar
- Silva D, Cortez CM, Cunhua-Bastos J, Louro SR: Methyl parathion interaction with human and bovine serum albumin. Toxicol Lett. 2004, 147: 53-61.View ArticlePubMedGoogle Scholar
- Uddin SJ, Shilpi JA, Murshid GMM, Rahman AA, Sarder MM, Alam MA: Determination of the binding sites of arsenic on bovine serum albumin using warfarin (site-I specific probe) and diazepam (site-II specific probe). Journal of Biological Sciences. 2004, 4: 609-612.View ArticleGoogle Scholar
- Svozil D, Kalina J, Omelka M, Schneider B: DNA conformations and their sequence preferences. Nucleic Acids Res. 2008, 36: 3690-3706.PubMed CentralView ArticlePubMedGoogle Scholar
- Goodwin KD, Lewis MA, Long EC, Georgiadis MM: Crystal structure of DNA-bound Co(III)·bleomycin B2:Insights on intercalation and minor groove binding. Proc Natl Acad Sci USA. 2008, 105: 5052-5056.PubMed CentralView ArticlePubMedGoogle Scholar
- Barcelo F, Scotta C, Ortiz-Lombardý M, Méndez C, Salas JA, Portugal J: Entropically-driven binding of mithramycin in the minor groove of C/G-rich DNA sequences. Nucleic Acids Res. 2007, 35: 2215-2226.PubMed CentralView ArticlePubMedGoogle Scholar
- Ghanayem BI, Witt KL, Kissling GE, Tice RR, Recio L: Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: Evidence consistent with a glycidamide-mediated effect. Mutation Res. 2005, 578: 284-297.View ArticlePubMedGoogle Scholar
- Adeeko A, Li D, Doucet J, Cooke GM, Trasler JM, Robaire B, Hales BF: Gestational Exposure to Persistent Organic Pollutants: Maternal Liver Residues, Pregnancy Outcome, and Effects on Hepatic Gene Expression Profiles in the Dam and Fetus. Toxicol Sci. 2003, 72: 242-252.View ArticlePubMedGoogle Scholar
- Baliga R, Crothers DM: On the kinetics of distamycin binding to its target sites on duplex DNA. Proc Natl Acad Sci USA. 2000, 97: 7814-7818.PubMed CentralView ArticlePubMedGoogle Scholar
- Kamei Y, Ohizumi H, Fujitani Y, Nemoto T, Tanaka T, Takahashi N, Kawada T, Miyoshi M, Ezaki O, Kakizuka A: PPARγ coactivator 1/βERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc Natl Acad Sci USA. 2003, 100: 12378-12383.PubMed CentralView ArticlePubMedGoogle Scholar
- Hiroi T, Okada K, Imaoka S, Osada M, Funae Y: Bisphenol A Binds to Protein Disulfide Isomerase and Inhibits Its Enzymatic and Hormone-Binding Activities. Endocrinology. 2006, 147: 2773-2780.View ArticlePubMedGoogle Scholar
- Olsen GW, Huang HY, Helzlsouer KJ, Hansen KJ, Butenhoff JL, Mandel JH: Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood. Environ Health Perspect. 2005, 113: 539-545.PubMed CentralView ArticlePubMedGoogle Scholar
- Nakayama S, Harada K, Inoue K, Sasaki K, Seery B, Saito N, Koizumi A: Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities. Environ Sci. 2005, 12: 293-313.PubMedGoogle Scholar
- Yamashita N, Kannan K, Taniyasu S, Horii Y, Petrick G, Gamo T: A global survey of perfluorinated acids in oceans. Mar Pollut Bull. 2005, 51: 658-668.View ArticlePubMedGoogle Scholar
- Giesy JP, Kannan K: Global Distribution of Perfluorooctane Sulfonate in Wildlife. Environ Sci Technol. 2001, 35: 1339-1342.View ArticlePubMedGoogle Scholar
- Kannan K, Koistinen J, Beckmen K, Evans T, Jones PD, Eero H, Nyman M, Giesy JP: Accumulation of perfluorooctane sulfonate in marine mammals. Environ Sci Technol. 2001, 35: 1593-1598.View ArticlePubMedGoogle Scholar
- Kannan K, Franson JC, Bowerman WW, Hansen KJ, Jones PD, Giesy JP: Perfluorooctane sulfonate in fisheating water birds including bald eagles and albatrosses. Environ Sci Technol. 2001, 35: 3065-3070.View ArticlePubMedGoogle Scholar
- Kannan K, Newsted J, Halbrook RS, Giesy JP: Perfluorooctanesulfonate and related fluorinated hydrocarbons in mink and river otters from the United States. Environ Sci Technol. 2002, 36: 2566-2571.View ArticlePubMedGoogle Scholar
- Kannan K, Corsolini S, Falandysz J, Oehme G, Focardi S, Giesy JP: Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and Mediterranean Seas. Environ Sci Technol. 2002, 36: 3210-3216.View ArticlePubMedGoogle Scholar
- Kannan K, Choi J, Iseki N, Senthilkumar K, Kim DH, Masunaga S, Giesy JP: Concentrations of perfluorinated acids in livers of birds from Japan and Korea. Chemosphere. 2002, 49: 225-231.View ArticlePubMedGoogle Scholar
- Kannan K, Corsolini S, Falandysz J, Fillman G, Kumar KS, Loganathan BG, Mohd MA, Olivero J, van Wouwe N, Yang JH, Aldous KM: Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol. 2004, 38: 4489-4495.View ArticlePubMedGoogle Scholar
- Smithwick M, Mabury SA, Solomon KR, Sonne C, Martin JW, Born EW, Dietz R, Derocher AE, Letcher RJ, Evans TJ, Gabrielsen GW, Nagy J, Stirling I, Taylor MK, Muir DC: Circumpolar study of perfluoroalkyl contaminants in Polar Bears (Ursus maritimus). Environ Sci Technol. 2005, 39: 5517-5523.View ArticlePubMedGoogle Scholar
- Karrman A, Mueller JF, Van Bavel B, Harden F, Toms LML, Lindstrom G: Levels of 12 Perfluorinated Chemicals in Pooled Australian Serum, Collected 2002–2003, in Relation to Age, Gender, and Region. Environ Sci Technol. 2006, 40: 3742-3748.View ArticlePubMedGoogle Scholar
- Bossi R, Riget FF, Dietz R, Sonne C, Fauser P, Dam M, Vorkamp K: Preliminary screening of perfluorooctane sulfonate (PFOS) and other fluorochemicals in fish, birds and marine mammals from Greenland and the Faroe Islands. Environ Pollut. 2005, 136: 323-329.View ArticlePubMedGoogle Scholar
- Apelberg BJ, Witter FR, Herbstman JB, Calafat AM, Halden RU, Needham LL, Goldman LR: Cord Serum Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) in Relation to Weight and Size at Birth. Environ Health Perspect. 2007, 115: 1670-1676.PubMed CentralView ArticlePubMedGoogle Scholar
- Apelberg BJ, Goldman LR, Calafat AM, Herbstman JB, Kuklenyik Z, Heidler J, Needham LL, Halden RU, Witter FR: Determinants of Fetal Exposure to Polyfluoroalkyl Compounds in Baltimore, Maryland. Environ Sci Technol. 2007, 41: 3891-3897.View ArticlePubMedGoogle Scholar
- Inoue K, Okada F, Ito R, Kato S, Sasaki S, Nakajima S, Uno A, Saijo Y, Sata F, Yoshimura Y, Kishi R, Nakazawa H: Perfluorooctane Sulfonate (PFOS) and Related Perfluorinated Compounds in Human Maternal and Cord Blood Samples: Assessment of PFOS Exposure in a Susceptible Population during Pregnancy. Environ Health Perspect. 2004, 112: 1204-1207.PubMed CentralView ArticlePubMedGoogle Scholar
- Kelly BC, Ikonomou MG, Blair JD, Morin AE, Gobas FAPC: Food Web-Specific Biomagnification of Persistent Organic Pollutants. Science. 2007, 317: 236-239.View ArticlePubMedGoogle Scholar
- Fuentes S, Colomina MT, Vicens P, Franco-Pons N, Domingo JL: Concurrent Exposure to Perfluorooctane Sulfonate and Restraint Stress during Pregnancy in Mice: Effects on Postnatal Development and Behavior of the Offspring. Toxicol Sci. 2007, 98: 589-598.View ArticlePubMedGoogle Scholar
- Fuentes S, Colomina MT, Vicens P, Domingo JL: Influence of maternal restraint stress on the long-lasting effects induced by prenatal exposure to perfluorooctane sulfonate (PFOS) in mice. Toxicol Lett. 2007, 171: 162-170.View ArticlePubMedGoogle Scholar
- Fuentes S, Colomina MT, Rodriguez J, Vicens P, Domingo JL: Interactions in developmental toxicology: Concurrent exposure to perfluorooctane sulfonate (PFOS) and stress in pregnant mice. Toxicol Lett. 2006, 164: 81-89.View ArticlePubMedGoogle Scholar
- Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Barbee BD, Richards JH, Butenhoff JL, Stevenson LA, Lau C: Exposure to Perfluorooctane Sulfonate during Pregnancy in Rat and Mouse. I: Maternal and Prenatal Evaluations. Toxicol Sci. 2003, 74: 369-381.View ArticlePubMedGoogle Scholar
- Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA: Exposure to Perfluorooctane Sulfonate during Pregnancy in Rat and Mouse. II: Postnatal Evaluation. Toxicol Sci. 2003, 74: 382-392.View ArticlePubMedGoogle Scholar
- Lau C, Butenhoff JL, Rogers JM: The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol. 2004, 198: 231-241.View ArticlePubMedGoogle Scholar
- Slotkin TA, MacKillop EA, Melnick RL, Thayer KA, Seidler FJ: Developmental Neurotoxicity of Perfluorinated Chemicals Modeled in Vitro. Environ Health Perspect. 2008, 116: 716-722.PubMed CentralView ArticlePubMedGoogle Scholar
- Johansson N, Fredriksson A, Eriksson P: Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. NeuroToxicology. 2008, 29: 160-169.View ArticlePubMedGoogle Scholar
- Harada KH, Ishii TM, Takatsuka K, Koizumi A, Ohmori H: Effects of perfluorooctane sulfonate on action potentials and currents in cultured rat cerebellar Purkinje cells. Biochem Biophys Res Commun. 2006, 351: 240-245.View ArticlePubMedGoogle Scholar
- Austin ME, Kasturi BS, Barber M, Kannan K, MohanKumar PS, MohanKumar SMJ: Neuroendocrine Effects of Perfluorooctane Sulfonate in Rats. Environ Health Perspect. 2003, 111: 1485-1489.PubMed CentralView ArticlePubMedGoogle Scholar
- Peden-Adams MM, Keller JM, EuDaly JG, Berger J, Gilkeson GS, Keil DE: Suppression of Humoral Immunity in Mice Following Exposure to Perfluorooctane Sulfonate. Toxicol Sci. 2008, 104: 144-154.View ArticlePubMedGoogle Scholar
- Keil DE, Mehlmann T, Butterworth L, Peden-Adams MM: Gestational Exposure to Perfluorooctane Sulfonate Suppresses Immune Function in B6C3F1 Mice. Toxicol Sci. 2008, 103: 77-85.View ArticlePubMedGoogle Scholar
- Upham BL, Deocampo ND, Wurl B, Trosko JE: Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail. Int J Cancer. 1998, 78: 491-495.View ArticlePubMedGoogle Scholar
- Hu W, Jones PD, Upham BL, Trosko JE, Lau C, Giesy JP: Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo. Toxicol Sci. 2002, 68: 429-436.View ArticlePubMedGoogle Scholar
- Shipley JM, Hurst CH, Tanaka SS, DeRoos FL, Butenhoff JL, Seacat AM, Waxman DJ: Trans-activation of PPAR alpha and induction of PPAR alpha target genes by perfluorooctane-based chemicals. Toxicol Sci. 2004, 80: 151-160.View ArticlePubMedGoogle Scholar
- Takacs ML, Abbott BD: Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol Sci. 2007, 95: 108-117.View ArticlePubMedGoogle Scholar
- Harada K, Xu F, Ono K, Iijima T, Koizumi A: Effects of PFOS and PFOA on L-type Ca2+ currents in guinea-pig ventricular myocytes. Biochem Biophys Res Commun. 2005, 329: 487-494.View ArticlePubMedGoogle Scholar
- Starkov AA, Wallace KB: Structrual Determinants of Fluorochemical-Induced Mitochondrial Dysfunction. Toxicol Sci. 2002, 66: 244-252.View ArticlePubMedGoogle Scholar
- Kennedy GL, Butenhoff JL, Olsen GW, O'Connor JC, Seacat AM, Perkins RG, Biegel LB, Murphy SR, Farrar DG: The toxicology of perfluorooctanoate. Crit Rev Toxicol. 2004, 34: 351-384.View ArticlePubMedGoogle Scholar
- Seacat AM, Thomford PJ, Hansen KJ, Olsen GW, Case MT, Butenhoff JL: Subchronic toxicity studies on perfluoroctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci. 2002, 68: 249-264.View ArticlePubMedGoogle Scholar
- Yeung LWY, Guruge KS, Yamanaka N, Miyazaki S, Lam PKS: Differential expression of chicken hepatic genes responsive to PFOA and PFOS. Toxicology. 2007, 237: 111-125.View ArticlePubMedGoogle Scholar
- Zhang HY, Macara IG: The PAR-6 Polarity Protein Regulates Dendritic Spine Morphogenesis through p190 RhoGAP and the Rho GTPase. Dev Cell. 2008, 14: 216-226.PubMed CentralView ArticlePubMedGoogle Scholar
- Kraut DA, Carroll KS, Herschlag D: Challenges in enzyme mechanism and energetics. Annu Rev Biochem. 2003, 72: 517-571.View ArticlePubMedGoogle Scholar
- Qu XG, Trent JO, Fokt I, Priebe W, Chaires JB: Allosteric, chiral-selective drug binding to DNA. Proc Natl Acad Sci USA. 2000, 97: 12032-12037.PubMed CentralView ArticlePubMedGoogle Scholar
- Olsen GL, Louie EA, Drobny GP, Sigurdsson ST: Determination of DNA minor groove width in distamycin-DNA complexes by solid-state NMR. Nucleic Acids Res. 2003, 31: 5084-5089.PubMed CentralView ArticlePubMedGoogle Scholar
- Peh WYX, Reimhult E, Teh HF, Thomsen JS, Su X: Understanding Ligand Binding Effects on the Conformation of Estrogen Receptor a-DNA Complexes: A Combinational Quartz Crystal Microbalance with Dissipation and Surface Plasmon Resonance Study. Biophys J. 2007, 92: 4415-4423.PubMed CentralView ArticlePubMedGoogle Scholar
- Li L, Gao HW, Ren JR, Chen L, Li YC, Zhao JF, Zhao HP, Yuan Y: Binding of Sudan II and IV to lecithin liposomes and E. coli membranes: insights into the toxicity of hydrophobic azo dyes. BMC Struct Biol. 2007, 7: 16-PubMed CentralView ArticlePubMedGoogle Scholar
- GAO HW, Zhao JF, Yang QZ, Liu XH, Chen L, Pan LT: Non-covalent Interaction of 2', 4', 5', 7'-Tetrabromo-4, 5, 6, 7-Tetrachlorofluorescein with Proteins and Its Applications. Proteomics. 2006, 6: 5140-5151.View ArticlePubMedGoogle Scholar
- Gao HW, Xu Q, Chen L, Wang SL, Wang Y, Wu LL, Yuan Y: Potential Protein Toxicity of Synthetic Pigments: Binding of Poncean S to Human Serum Albumin. Biophys J. 2008, 94: 906-917.PubMed CentralView ArticlePubMedGoogle Scholar
- Luebker DJ, Hansen KJ, Bass NM, Butenhoff JL, Seacat AM: Interactions of flurochemicals with rat liver fatty acid-binding protein. Toxicology. 2002, 176: 175-185.View ArticlePubMedGoogle Scholar
- Jones PD, Hu WY, Coen WD, Newsted JL, Giesy JP: Binding of perfluorinated fatty acids to serum proteins. Environ Toxicol Chem. 2003, 22: 2639-2649.View ArticlePubMedGoogle Scholar
- Malkov V, Voloshin O, Soyfer VN, Frank-Kamenetskii MD: Cation and sequence effects on stability of intermolecular pyrimidine-purine-purine triplex. Nucleic Acids Res. 1993, 21: 585-591.PubMed CentralView ArticlePubMedGoogle Scholar
- Singleton SF, Dervan PB: Temperature dependence of the energetics of oligonucleotide-directed triple-helix formation at a single DNA site. Journal of the American Chemical Society. 1994, 116: 10376-10382.View ArticleGoogle Scholar
- Gao HW, Yang JX, Jiang J, Yu LQ: Langmuir aggregation of chromophore in biomacromolecule and its application: interaction of picramine CA (PCA) with proteins. Supramol Chem. 2002, 14: 315-321.View ArticleGoogle Scholar
- Dockal M, Carter DC, Ruker F: Conformational transitions of the three recombinant domains of human serum albumin depending on pH. J Biol Chem. 2000, 275: 3042-3050.View ArticlePubMedGoogle Scholar
- Behera GB, Mishra BK, Behera PK, Panda M: Fluorescent probes for structural and distance effect studies in micelles, reversed micelles and micromulsions. Adv Colloid Interface Sci. 1999, 82: 1-42.View ArticleGoogle Scholar
- Yi PG, Yu QS, Shang ZC, Guo M: Study on the interaction between chlortetracycline and bovine serum albumin. Chinese Journal Chemical Physics. 2003, 16: 420-425.Google Scholar
- Lah J, Drobnak I, Dolinar M, Vesnaver G: What drives the binding of minor groove-directed ligands to DNA hairpins?. Nucleic Acids Res. 2007, 36: 897-904.PubMed CentralView ArticlePubMedGoogle Scholar
- Chen SH, Suzuki CK, Wu SH: Thermodynamic characterization of specific interactions between the human Lon protease and G-quartet DNA. Nucleic Acids Res. 2008, 36: 1273-1287.PubMed CentralView ArticlePubMedGoogle Scholar
- Yang M: Molecular recognition of DNA targeting small molecule drugs. Journal of Peking University (Health Sciences). 1998, 30: 97-99.Google Scholar
- Xie MX, Xu XY, Wang YD: Interaction between hesperetin and human serum albumin revealed by spectroscopic methods. Biochim Biophys Acta. 2005, 1724: 215-224.View ArticlePubMedGoogle Scholar
- Desai A, Lee C, Sharma L, Sharma A: Lysozyme refolding with cyclodextrins, structure-activity relationship. Biochimie. 2006, 88: 1435-1445.View ArticlePubMedGoogle Scholar
- Piekarska B, Skowronek M, Rybarska J, Stopa B, Roterman I, Konieczny L: Congo red-stabilized intermediates in the lambda light chain transition from native to molten state. Biochimie. 1996, 78: 183-189.View ArticlePubMedGoogle Scholar
- Gao HW, Qian Y, Hu ZJ: Tetraiodophenolsuphonphthalein as a spectral substitute to characterize the complexation between cationic and anionic surfactant. J Colloid Interface Sci. 2004, 279: 244-252.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.